Trial Outcomes & Findings for Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa (NCT NCT00346476)

Results Overview

Recruitment status

COMPLETED

Target enrollment

1250 participants

Primary outcome timeframe

At Year 5

Results posted on

2011-02-11

Participant Flow

Participant milestones

Participant milestones
Measure	Participants Individuals in the Masiphumelele Township of Cape Town, South Africa, who have been potentially exposed to TB and/or HIV
Overall Study STARTED	1250
Overall Study COMPLETED	1250
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Participants n=1250 Participants Individuals in the Masiphumelele Township of Cape Town, South Africa, who have been potentially exposed to TB and/or HIV
Age, Categorical <=18 years	55 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	1185 Participants n=5 Participants
Age, Categorical >=65 years	10 Participants n=5 Participants
Age Continuous	28.9 years STANDARD_DEVIATION 9.5 • n=5 Participants
Sex: Female, Male Female	602 Participants n=5 Participants
Sex: Female, Male Male	648 Participants n=5 Participants
Region of Enrollment South Africa	1250 participants n=5 Participants

PRIMARY outcome

Timeframe: At Year 5

Outcome measures

Outcome measures
Measure	Participants n=1250 Participants Individuals in the Masiphumelele Township of Cape Town, South Africa, who have been potentially exposed to TB and/or HIV
Number of Participants With Microbiologically Confirmed Tuberculosis Infection	20 participants

PRIMARY outcome

Timeframe: At Year 5

Outcome measures

Outcome measures
Measure	Participants n=1250 Participants Individuals in the Masiphumelele Township of Cape Town, South Africa, who have been potentially exposed to TB and/or HIV
Number of Participants With HIV Infection	306 participants

SECONDARY outcome

Timeframe: Year 1 to Year 5

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Year 1 to Year 5

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Year 1 to Year 5

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: At Year 5

Outcome measures

Outcome data not reported

Adverse Events

Participants

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof LG Bekker

Desmond Tutu HIV Centre

Phone: +27216506966

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place